other_material
confidence high
sentiment neutral
materiality 0.60
KALA BIO enters $15M at-market offering agreement with H.C. Wainwright
KALA BIO, Inc.
- Aggregate market value of shares eligible for sale under ATM prospectus supplement currently $15,000,000.
- Sales commission to H.C. Wainwright set at 3.0% of gross sales price.
- Company has no obligation to sell any shares under the agreement; either party may suspend offerings.
- Subject to terms, Wainwright may sell shares on Nasdaq or in privately negotiated transactions.